These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39347626)

  • 1. Oral Tranexamic Acid for Prevention and Treatment of Postinflammatory Hyperpigmentation.
    Minasyan M; Hogan S; Lal K
    Dermatol Surg; 2024 Dec; 50(12S):S219-S224. PubMed ID: 39347626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Best Mode of Delivery for Tranexamic Acid in Post-Inflammatory Hyperpigmentation: A Systematic Review.
    Alsharif SH; Alghamdi AS; Alwayel ZA; Alaklabi SN; Alyamani NA; Sabsabee MA; Bu Izran DAA; Alajlan AM
    Clin Cosmet Investig Dermatol; 2022; 15():2873-2882. PubMed ID: 36597522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
    Mahjoub TT; Milibary HH
    J Cosmet Dermatol; 2023 Apr; 22(4):1157-1162. PubMed ID: 36575866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
    Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
    Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Sunscreen in Melasma and Postinflammatory Hyperpigmentation.
    Fatima S; Braunberger T; Mohammad TF; Kohli I; Hamzavi IH
    Indian J Dermatol; 2020; 65(1):5-10. PubMed ID: 32029932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation.
    Lindgren AL; Austin AH; Welsh KM
    J Drugs Dermatol; 2021 Mar; 20(3):344-345. PubMed ID: 33683077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
    Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
    J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-Assisted Drug Delivery of Tranexamic Acid by Picosecond Laser in Postinflammatory Hyperpigmentation: A Split-Area Double Blind Randomized Prospective Study.
    Lin CH; Tsai YJ; Lin KC; Hsieh MH; Lin HP; Hsu SY; Tsai HH; Hsieh CH
    Photobiomodul Photomed Laser Surg; 2021 Nov; 39(11):711-715. PubMed ID: 34762534
    [No Abstract]   [Full Text] [Related]  

  • 10. Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update.
    Chen T; Xue J; Wang Q
    Clin Cosmet Investig Dermatol; 2024; 17():2151-2163. PubMed ID: 39350932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser.
    Kato H; Araki J; Eto H; Doi K; Hirai R; Kuno S; Higashino T; Yoshimura K
    Dermatol Surg; 2011 May; 37(5):605-10. PubMed ID: 21457392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors.
    Bin Dakhil A; Shadid A; Altalhab S
    Dermatol Reports; 2023 Dec; 15(4):9703. PubMed ID: 38205425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
    Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
    Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
    Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
    Lueangarun S; Namboonlue C; Tempark T
    J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
    Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
    J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment for postinflammatory hyperpigmentation: a systematic review.
    Tan MG; Kim WB; Jo CE; Nabieva K; Kirshen C; Ortiz AE
    J Dermatolog Treat; 2022 Aug; 33(5):2518-2526. PubMed ID: 34525885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
    Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
    Savory SA; Agim NG; Mao R; Peter S; Wang C; Maldonado G; Bearden Dietert J; Lieu TJ; Wang C; Pretzlaff K; Das S; Vandergriff T; Lopez IE; Litzner BR; Hynan LS; Arellano-Mendoza MI; Bergstresser PR; Pandya AG
    J Am Acad Dermatol; 2014 Jan; 70(1):108-14. PubMed ID: 24176524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.